EUPATI Switzerland/ Schweiz / Suisse / Svizzera (EUPATI CH)

What EUPATI Switzerland/ Schweiz / Suisse / Svizzera (EUPATI CH) does

EUPATI Switzerland (EUPATI CH) is a non-profit association under Swiss law, formally registered on October 4, 2016, and tracing its origins to a 2013 informal network of Swiss healthcare stakeholders. The organization provides structured education and training programs that enable patients and patient advocates to participate meaningfully in clinical research, regulatory processes, and therapeutic innovation within Switzerland. Its core offerings include a 6-module self-study online course ("Patientenbeteiligung in der medizinischen Forschung") available in German, French, and Italian, and an 8-month expert training program ("EUPATI Schweiz Patientenexpertin/-experte") developed and delivered jointly with the Department of Clinical Research at University Hospital Basel. The 23 graduates of the first expert cohort (announced September 2023) form the nucleus of an EUPATI Fellows network that engages with research teams, the Swiss National Science Foundation, and regulatory bodies.

The organization's revenue model is mission-driven rather than commercial, combining individual and institutional membership fees (CHF 30, CHF 50+, and CHF 2,000 supporting tiers), CHF 100 administrative fees for course certificates, donations, and grant funding from public sources (SNF, SAMW) plus pharmaceutical sponsorships (Janssen, Takeda, Bayer). Its flagship Swiss Patient Forum has been held annually since 2017, free to attend, and serves as a convening platform for patient organizations, healthcare professionals, industry, and regulators. EUPATI CH operates as part of the broader EUPATI (European Patient Academy on Therapeutic Innovation) network while maintaining its own Swiss legal entity, headquarters in Zurich, and a small staff of approximately 8 employees.

Name

EUPATI Switzerland/ Schweiz / Suisse / Svizzera (EUPATI CH)

Legal name

Association EUPATI CH

Website

https://ch.eupati.eu

Company type

Private

Founded year

2016

Operating status

Operating

Short description

EUPATI Switzerland is a non-profit association that delivers patient education and training programs in German, French, and Italian to enable meaningful patient participation in Switzerland's clinical research, regulatory, and therapeutic innovation ecosystem.

Ownership category

akta.pro rank

Product category

Patient Advocacy Education

akta.pro primary industry

Community Health, Health Promotion & Behavior Change (SBCC) (BPADAIAL)

Keywords

• Patient education programs
• Clinical research training
• Patient engagement services
• Therapeutic innovation education
• Medicines R&D training

Headquarters

HQ city

Zürich

HQ country

Switzerland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure, Others

Revenue model

1. Membership Fees: Annual membership fees from individuals (CHF 30), institutions (minimum CHF 50), and supporting institutions (CHF 2000). Membership is open to patients, patient advocates, academics, healthcare professionals, industry representatives, government officials, and other stakeholders.
2. Donations: EUPATI CH is a nonprofit organization that accepts donations to support its mission and training courses. Donors are acknowledged publicly, with funds managed through dedicated Education Fund and Research Fund accounts.
3. Training Course Administration: Administrative fee of CHF 100 for issuing certificates upon completion of the online course modules.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Core offering

EUPATI CH is a Swiss nonprofit association that delivers structured education and training programs for patients and patient advocates on clinical research and therapeutic innovation. Its core offerings are a 6-module self-study online course in German, French, and Italian, an 8-month expert-level training course developed with University Hospital Basel's Department of Clinical Research, and an annual Swiss Patient Forum event. The organization also runs a membership program connecting patients, academia, industry, and regulators.

Product overview

EUPATI Switzerland is a non-profit association (under Swiss law, established October 4, 2016) that provides patient education and training programs focused on enabling meaningful patient engagement in therapeutic innovation. The organization operates a portfolio of educational products: the Online-Kurs (self-study course) and the Ausbildungskurs zur/zum «EUPATI Schweiz Patientenexpertin/-experten» (expert training course) form the core training offerings, both developed in partnership with the University of Basel Department of Clinical Research. The flagship Swiss Patient Forum is an annual event platform for networking and discussion. The EUPATI Fellows Program connects trained expert patients, while newsletters and publications disseminate knowledge. Membership is open to all interested parties including patients, healthcare professionals, and industry representatives. The organization also maintains a multilingual presence in German, French, Italian, and English.

Differentiator

Problem solved

Functional benefit

Brands

• Swiss Patient Forum: EUPATI CH's flagship annual event bringing together patients, healthcare professionals, and stakeholders for discussion on patient involvement in healthcare.

Products and services

• Online-Kurs: Patientenbeteiligung in der medizinischen Forschung Self-study online course for patients, family members, and interested laypersons explaining how medical research works and how patients can actively participate in research projects. Contains 6 modules covering research basics, ethical/legal aspects, and knowledge transfer. Available in German, French, and Italian; free access with optional CHF 100 certificate.
• Ausbildungskurs zur/zum «EUPATI Schweiz Patientenexpertin/-experten» Expert-level 8-month training program preparing patients to engage meaningfully in clinical research. Developed with University of Basel Department of Clinical Research. Covers the Swiss-specific clinical research landscape and enables graduates to participate in research teams or funding institutions such as the Swiss National Science Foundation.
• Swiss Patient Forum Annual flagship event bringing together patients, patient advocates, healthcare professionals, and stakeholders. Held annually since 2017 in Bern, featuring workshops, panel discussions, and networking opportunities focused on patient involvement in healthcare and research. Participation is free of charge.
• Membership Program Open membership program for patients, patient advocates, academics, healthcare professionals, industry representatives, government officials, and medical journalists to join the Swiss network promoting patient involvement in therapeutic innovation. Annual fees: CHF 30 (individual), minimum CHF 50 (institution), CHF 2,000 (supporting institution), with hardship clause available.

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Nine partnerships are on record, tiered key, core and founding.

• Schweizerische Akademie der Medizinischen Wissenschaften (SAMW)keyStrategic or Co-development Partner · 1 January 2023Supported the development of the first EUPATI CH training course. SAMW is the Swiss Academy of Medical Sciences.
• Departement für Klinische Forschung (DKF), University of BaselcoreStrategic or Co-development Partner · 1 January 2022Jointly developed the 8-month expert training program 'EUPATI Schweiz Patientenexpertin/-experte' and the 6-module online course 'Patientenbeteiligung in der medizinischen Forschung'. The DKF delivers the courses and handles enrollment.
• Schweizerische Patientenorganisation (SPO)keyStrategic or Co-development Partner · 1 January 2022Supporting organization for the 'EUPATI Schweiz Patientenexpertin/-experte' training course.
• Various Patient Organizations and Pharmaceutical IndustrycoreStrategic or Co-development Partner · 1 January 2016Representatives from patient organizations and pharmaceutical industry joined the network in 2014 and collaborated on public events raising awareness for EUPATI in Switzerland.
• SwissmediccoreStrategic or Co-development Partner · 1 January 2014The Swiss Agency for Therapeutic Products began collaborating closely with the network shortly after its founding. Swissmedic is the Swiss regulatory authority for therapeutic products.
• Positivrat SchweizfoundingStrategic or Co-development Partner · 1 January 2013One of the four founding organizations that created the informal network of stakeholders in Switzerland interested in medicines R&D and patient involvement in 2013.
• Patient Advocates for Cancer Research and Treatment (PACRT)foundingStrategic or Co-development Partner · 1 January 2013One of the four founding organizations that created the informal network of stakeholders in Switzerland in 2013, focused on cancer research and patient involvement.
• Swiss Clinical Trial Organisation (SCTO)foundingStrategic or Co-development Partner · 1 January 2013One of the four founding organizations that created the informal network of stakeholders in Switzerland in 2013. EUPATI CH's office is located at SCTO's address in Bern.
• University Hospital Basel (USB)foundingStrategic or Co-development Partner · 1 January 2013One of the four founding organizations. The Departement für Klinische Forschung (DKF) of University Hospital Basel collaborated with EUPATI CH to develop training programs adapted to Swiss requirements.

Scale indicators3 records

Recent moves7 records

Expansion highlights4 records

Direct peers

• EUPATI (European Patient Academy on Therapeutic Innovation): The pan-European umbrella academy of which EUPATI CH is the Swiss national chapter. Both deliver structured patient education curricula on medicines R&D; EUPATI CH adapts and localizes these materials for Switzerland.
• Patient Focused Medicines Development (PFMD): Global multi-stakeholder coalition building tools and frameworks for systematic patient engagement in medicines development. Highly comparable to EUPATI CH's mission of producing trained patient experts and engagement methodologies.
• European Patients' Academy on Therapeutic Innovation – Fellows Network: The EUPATI Fellows program, with 150+ alumni including 8 from Switzerland, that EUPATI CH's expert training directly feeds into. Operates as the natural graduate community for EUPATI CH-trained patient experts.

Broad incumbents

• European Patients' Forum (EPF): Umbrella organization of European patient associations that advocates for patient involvement in EU health policy and research. Operates at a broader policy level than EUPATI CH but shares the patient-empowerment mandate.
• EURORDIS – Rare Diseases Europe: European patient alliance for rare diseases that runs patient training programs (e.g., EURORDIS Open Academy) and represents patient voices in regulatory and HTA processes. Comparable as a patient-training provider in clinical research contexts.
• Clinical Trials Transformation Initiative (CTTI): Public-private partnership co-founded by FDA and Duke that develops recommendations for patient engagement in clinical trials. Operates adjacent to EUPATI CH in shaping patient involvement practices and standards.
• DIA (Drug Information Association): Global life sciences membership organization that runs patient engagement programs, conferences, and training. Comparable as a convener of patient, industry, and regulator stakeholders in medicines development.
• International Alliance of Patients' Organizations (IAPO): Global alliance of patient organizations that delivers patient leadership and advocacy training. Comparable to EUPATI CH's mission of building patient capability to engage in health research and policy.

Emerging players

• FasterCures: Center of the Milken Institute focused on accelerating patient-driven R&D through patient engagement training and convening. Comparable as a non-profit building patient-expert capacity in biomedical research.
• Schweizerische Patientenorganisation (SPO): Swiss national patient organization that is a supporting partner of EUPATI CH's expert training course. Comparable as a Swiss-based patient advocacy body with overlapping constituents and complementary training offerings.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/Eupati.Switzerland

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about EUPATI Switzerland/ Schweiz / Suisse / Svizzera (EUPATI CH)